Abstract：Objective To standardize the clinical application of drugs and control the unreasonable increase of drug
cost. Methods The rational use of key monitoring drugs was specified through prescription review and administrative intervention,
under the measures of formulating special management methods and determining the list of key monitoring drugs. Information
construction was carried out to optimize its management. At the same time, the drug efficacy and economics of similar drugs with
large dosage were compared. The recommendations for clinical use was formed to provide more scientific reference for drug selection.
Results The main irrational drug use problems of the key monitoring drugs were off-label, overdose, overduration of treatment,
and treating contraindications. After optimizing the management, the irrational rate decreased from 1.41% to 0.67%, the total sales
volume of the key monitoring drugs decreased from 27.8464 million yuan to 17.7242 million yuan, and the per capita drug cost was
saved by 580.07 yuan. The use of the key monitoring drugs in our hospital became more standardized, and the proportion of the key
monitoring drugs decreased significantly. Conclusion Scientific management of key monitoring drugs can save unnecessary drug
expenses for patients and provide practical and effective reference value for the rational use of key monitoring drugs in other hospitals.
胡浩然a
，杨静b
，郑磊b
，张彧飞a. 我院重点监控药品科学化管理的探索和实践[J]. 中国医疗设备, 2020, 35(8): 144-147.
HU Haorana
, YANG Jingb
, ZHENG Leib
, ZHANG Yufeia. Exploration and Practice of Scientific Management of Key Monitoring Drugs in Our Hospital. China Medical Devices, 2020, 35(8): 144-147.
